Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Trials|October 11, 2023
Factors that influence women's enrolment and ongoing participation in a partially decentralised randomised controlled dermatology trial: a qualitative interview study with participants in the SAFA (Spironolactone for Adult Female Acne) trialCherish Boxall, Susanne Renz, Zina Eminton, et al.
Trials|May 11, 2021
Developing the INCLUDE Ethnicity Framework-a tool to help trialists design trials that better reflect the communities they serveShaun Treweek, Katie Banister, Peter Bower, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|November 28, 2023
Citizen science to improve patient and public involvement in GUideline Implementation in oral health and DEntistry (the GUIDE platform)Annabel Hosie, Maria Firdaus, Jan Clarkson, et al.
The British Journal of Dermatology|July 18, 2026
Views and experiences of young people and their parents of managing acne: qualitative interview studyStephanie Easton, Rosie Essery, Mary Steele, et al.
BMJ Open|November 17, 2025
Multicancer early detection in a cohort of patients with confirmed and suspected cancer by measuring plasma amino acid cross sections with the Enlighten test: MODERNISED protocolSam Wilding, Victoria Goss, Wesley Sukdao, et al.
BMJ Open|August 27, 2021
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult womenSusanne Renz, Fay Chinnery, Beth Stuart, et al.
BMJ Open|December 11, 2023
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trialSarah Pyne, Tracey H Sach, Megan Lawrence, et al.
Health Technology Assessment (Winchester, England)|September 13, 2024
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCTMiriam Santer, Megan Lawrence, Sarah Pyne, et al.
BMJ (Clinical Research Ed.)|May 16, 2023
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trialMiriam Santer, Megan Lawrence, Susanne Renz, et al.
Trials|August 27, 2025
Social media recruitment enhances participant diversity in dermatology clinical trial: findings from the SAFA trialCherish Boxall, Susanne Renz, Beth Stuart, et al.
Pageof 3